Related Experiment Videos

Unmasking accessory pathway conduction with adenosine-induced atrioventricular nodal block after radiofrequency

K W Walker1, J H McAnulty, J Kron

  • 1Division of Cardiology, Oregon Health Sciences University, Portland.

Chest
|November 1, 1993
PubMed

Insights

Radiofrequency catheter ablation effectively treats Wolff-Parkinson-White syndrome, but recurrence can happen. Intravenous adenosine can reveal hidden accessory pathway conduction, guiding further treatment and improving long-term success rates.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Medical Devices

Background:

  • Radiofrequency catheter ablation is a primary treatment for Wolff-Parkinson-White syndrome.
  • Accessory pathway conduction recurrence occurs in 5-9% of patients post-ablation.
  • Identifying residual or latent accessory pathways is crucial for long-term treatment success.

Observation:

  • Two cases are presented where intravenous adenosine administration unmasked persistent accessory pathway conduction after seemingly successful radiofrequency ablation.
  • Adenosine's ability to reveal latent accessory pathways was observed in these patients.

Findings:

  • Intravenous adenosine can identify persistent accessory pathway conduction that may be missed by initial ablation assessment.
  • This diagnostic capability of adenosine provides a clear indication for repeat or additional ablative procedures.

Implications:

  • Adenosine administration post-ablation may enhance the long-term efficacy of radiofrequency catheter ablation for accessory pathways.
  • This approach could reduce recurrence rates by ensuring complete elimination of accessory pathway conduction.
  • The use of adenosine represents a potential strategy to improve patient outcomes in Wolff-Parkinson-White syndrome management.

Related Concept Videos